Combined assessment of reflow and collateral blood flow by myocardial contrast echocardiography after acute reperfused myocardial infarction

OBJECTIVE To evaluate the combined assessment of reflow and collateral blood flow by myocardial contrast echocardiography after myocardial infarction. DESIGN Myocardial contrast echocardiography was performed in patients with acute myocardial infarction shortly after successful coronary reperfusion (TIMI 3 patency) by direct angioplasty. Collateral flow was assessed before coronary angioplasty, and contrast reflow was evaluated 15 minutes after reperfusion. The presence of contractile reserve was assessed by low dose dobutamine echocardiography (5 to 15 μg/kg/min) at (mean (SD)) 3 (2) days after myocardial infarction. Recovery of segmental function (myocardial viability) was evaluated by resting echocardiography at a two month follow up. The study was prospective. PATIENTS 35 consecutive patients referred for acute transmural myocardial infarction. RESULTS Contrast reflow was observed in 20 patients (57%) and collateral flow in 14 (40%). Contrast reflow and collateral contrast flow were both correlated with reversible dysfunction on initial dobutamine echocardiography and at follow up (p < 0.05). The presence of reflow or collateral flow on myocardial contrast echocardiography was a highly sensitive (100%) but weakly specific (60%) indicator of segmental dysfunction recovery. Simultaneous presence of contrast reflow and collateral flow was more specific of reversible dysfunction than reflow alone (90% v 60%). CONCLUSIONS Combined assessment of reflow and collateral blood flow enhanced the sensitivity of myocardial contrast echocardiography in predicting myocardial viability after acute, reperfused myocardial infarction. The simultaneous presence of reflow and collateral blood flow was highly specific of recovery of segmental dysfunction.

[1]  T. Marwick.  The viable myocardium: epidemiology, detection, and clinical implications , 1998, The Lancet.

[2]  U. Deligonul,et al.  Effect of significant two-vessel versus one-vessel coronary artery stenosis on myocardial contrast defects observed with intermittent harmonic imaging after intravenous contrast injection during dobutamine stress echocardiography. , 1997, Journal of the American College of Cardiology.

[3]  S. Kaul,et al.  Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography. , 1997, Circulation.

[4]  A R Jayaweera,et al.  Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? , 1997, Circulation.

[5]  F. Leclercq,et al.  Myocardial viability assessed by dobutamine echocardiography in acute myocardial infarction after successful primary coronary angioplasty. , 1997, The American journal of cardiology.

[6]  Jeroen J. Bax,et al.  FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo. , 1997, European heart journal.

[7]  C. Autore,et al.  Combined use of dobutamine echocardiography and myocardial contrast echocardiography in predicting regional dysfunction recovery after coronary revascularization in patients with recent myocardial infarction. , 1997, European heart journal.

[8]  P. Colonna,et al.  Functional role of microvascular integrity in patients with infarct-related artery patency after acute myocardial infarction. , 1997, European heart journal.

[9]  A. L'Abbate,et al.  Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. , 1996, Journal of the American College of Cardiology.

[10]  P. Colonna,et al.  Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. , 1996, The American journal of cardiology.

[11]  S. Iliceto,et al.  Myocardial contrast echocardiography in acute myocardial infarction. Pathophysiological background and clinical applications. , 1996, European heart journal.

[12]  E. Picano,et al.  Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contrast echocardiography. , 1996, European heart journal.

[13]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[14]  P. Grayburn,et al.  Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. , 1995, Circulation.

[15]  E. Zajac,et al.  Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. , 1995, The American journal of cardiology.

[16]  S. Kaul.  Dobutamine echocardiography for determining myocardial viability after reperfusion: experimental and clinical observations. , 1995, European heart journal.

[17]  M. Hori,et al.  Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. , 1995, Circulation.

[18]  S. Kaul,et al.  Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. , 1995, The American journal of cardiology.

[19]  E. Picano,et al.  Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study , 1994, The Lancet.

[20]  S. Kaul,et al.  Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. , 1994, Circulation.

[21]  S. Kaul,et al.  Characterization of Spatial Patterns of Flow Within the Reperfused Myocardium by Myocardial Contrast Echocardiography Implications in Determining Extent of Myocardial Salvage , 1993, Circulation.

[22]  H Feigenbaum,et al.  Low‐Dose Dobutamine Echocardiography Detects Reversible Dysfunction After Thrombolytic Therapy of Acute Myocardial Infarction , 1993, Circulation.

[23]  S. Kaul,et al.  An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. , 1992, The New England journal of medicine.

[24]  S. Kaul,et al.  Functional Significance of Collateral Blood Flow in Patients With Recent Acute Myocardial Infarction: A Study Using Myocardial Contrast Echocardiography , 1992, Circulation.

[25]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[26]  J. Anderson,et al.  Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. , 1992, Journal of the American College of Cardiology.

[27]  L. Becker,et al.  Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[28]  T. Kamada,et al.  Coronary collaterals assessed with myocardial contrast echocardiography in healed myocardial infarction. , 1990, The American journal of cardiology.

[29]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  M. Cohen,et al.  Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. , 1989, Journal of the American College of Cardiology.

[31]  J. Carroll,et al.  Contrast Echocardiography During Coronary Arteriography in Humans: Perfusion and Anatomic Studies , 1988, Journal of the American College of Cardiology.

[32]  F. T. ten Cate,et al.  Evaluation of collateral blood flow by myocardial contrast enhanced echocardiography. , 1988, British heart journal.

[33]  S. Feinstein,et al.  Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility. , 1987, The American journal of cardiology.

[34]  A. Weyman,et al.  The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography. , 1987, Circulation.

[35]  M. Cohen,et al.  Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. , 1986, Circulation.

[36]  Y. Matoba,et al.  Importance of coronary collaterals for restoration of left ventricular function after intracoronary thrombolysis. , 1985, The American journal of cardiology.

[37]  C. Bloor,et al.  Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. , 1978, The American journal of cardiology.

[38]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.

[39]  G. Korb,et al.  Blood Supply of the Myocardium after Temporary Coronary Occlusion , 1966, Circulation research.